Equities
  • Price (USD)12.87
  • Today's Change-0.40 / -3.01%
  • Shares traded30.59k
  • 1 Year change-12.75%
  • Beta--
Data delayed at least 15 minutes, as of Jun 07 2024 20:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
STMN:SWX since
announced
Transaction
value
Alliedstar Medical Equipment Co LtdAnnounced21 Sep 202321 Sep 2023Announced-8.79%--
Gravitonas UABAnnounced18 Jul 202318 Jul 2023Announced-17.32%--
Med GrupeDeal completed18 Jul 202318 Jul 2023Deal completed-17.32%--
Data delayed at least 15 minutes, as of Jun 07 2024 16:34 BST.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
RhumbLine Advisers LPas of 31 Mar 202424.34k0.00%
Yorktown Management & Research Co., Inc.as of 30 Apr 202423.00k0.00%
GAMMA Investing LLCas of 31 Mar 20243.75k0.00%
DSM Capital Partners LLCas of 31 Mar 20241.90k0.00%
ShariaPortfolio, Inc.as of 09 May 20241.13k0.00%
Financial Gravity Asset Management, Inc.as of 31 Mar 2024501.000.00%
Front Row Advisors LLCas of 31 Mar 2024238.000.00%
Salomon & Ludwin LLCas of 31 Mar 2024141.000.00%
First Horizon Advisors, Inc.as of 31 Mar 202487.000.00%
PNC Investments LLCas of 31 Mar 202480.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.